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Abstract 
Ligaments and tendons are fibrous tissues with poor vascularity and limited regeneration capacity. Currently, a liga-
ment/tendon injury often require a surgical procedure using auto- or allografts that present some limitations. These 
inadequacies combined with the significant economic and health impact have prompted the development of tissue 
engineering approaches. Several natural and synthetic biodegradable polymers as well as composites, blends and 
hybrids based on such materials have been used to produce tendon and ligament scaffolds. Given the complex 
structure of native tissues, the production of fiber-based scaffolds has been the preferred option for tendon/ligament 
tissue engineering. Electrospinning and several textile methods such as twisting, braiding and knitting have been 
used to produce these scaffolds. This review focuses on the developments achieved in the preparation of tendon/
ligament scaffolds based on different biodegradable polymers. Several examples are overviewed and their processing 
methodologies, as well as their biological and mechanical performances, are discussed.
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Background
Tendons and ligaments have poor regeneration capacity 
with low cell density and low nutrient and oxygen require-
ments [1]. Injuries in these tissues such as in anterior cru-
ciate ligament (ACL) are frequent in athletes and in elder 
and active working people, which cause joint instability 
accompanied by pain, disability, progressing of degenera-
tive diseases and often, surgical interventions [2].
Current surgical reparative techniques rely on tissue 
replacement with auto- or allografts [3]. Despite excellent 
outcomes in terms of short-term results, serious com-
plications are related to their usage and 5-year studies 
show that patients have instability and pain [4]. The main 
problems about the use of autografts include the need 
of additional surgery with potential donor harvest site 
infection and pain. On the other hand, concerns about 
using allografts are limited graft availability or even the 
risk of disease transmission, bacterial infection and the 
possibility of immunogenic response elicited in the host 
[5–7]. The need to address the shortcomings of existing 
strategies has prompted the investigation of synthetic 
and non-degradable substitutes.
The development of non-degradable synthetic ACL 
substitutes has emerged since the early 1970s and offer 
advantages over autograft or allograft [7]. They allowed 
a rapid rehabilitation, avoid donor tissue morbidity, and 
provide improved knee stability, not losing their strength 
during tissue revascularization [8, 9]. Thus, in 1973, Pro-
plast, a combination of polyaramid fibers and ethylene 
polymers allowed cellular ingrowth and received Food 
and Drug Administration (FDA) approval for use as a 
ligament substitute [7]. Other commercial devices have 
emerged and have received the FDA approval as perma-
nent prosthetic devices [8], such as a Gore-Tex device 
made with woven polytetrafluoroethylene fibers [8, 10] 
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that was used between the mid 1980s and mid 1990s. 
In the early 1980s, the use of a polypropylene braid as a 
ligament augmentation device was proposed-Kennedy 
LAD device. Other devices were produced with polyes-
ter composites such as a polyester mesh in the case of the 
Leeds-Keio device. A second-generation of the Leeds-
Keio device was made available in 2003. Distinct Poly-
ethylene terephthalate devices were produced including 
Trevira-Hochfest, Proflex device, ProPivot and Ligament 
Augmentation and Reconstruction System (LARS) [10]. 
Initial enthusiasm for these devices was later faded by 
reports of complications and are not currently recom-
mended for ACL repair [11]. They supply enough initial 
tensile strength, but all fail over time, with several limita-
tions specific to their use: device creep, mechanical fail-
ure or mechanical mismatch with native tissue, problems 
with synovitis, chronic effusions, recurrent instability and 
early knee osteoarthritis [9–11]. Because of these com-
plications, FDA has since removed these synthetic ACL 
grafts from the market. Thus, no synthetic replacements 
for ACL reconstruction are unconditionally approved 
for medical use in the United States [7]. The deficien-
cies of current approaches combined with the significant 
impact of these injuries on the community in terms of 
social, economic and health have prompted the research 
of tissue engineering (TE) approaches for tendon/liga-
ment regeneration [2, 7, 9]. Thus, TE proposes alternative 
approaches combining cells with 3D scaffolds to mimic 
the mechanical and chemical cues of native extracellular 
matrix (ECM), and/or bioactive molecules to biochemi-
cally stimulate cells growth [9].
Specific cell types are incorporated into the scaffold 
which will be implanted into the host and interact with 
native cells and growth factors [12]. Interactions between 
cells and material’s scaffold are very important since 
materials could interfere with cells’ adhesion, prolifera-
tion and differentiation [8]. Ideally, cells should be readily 
available and have potential to proliferate and elaborate an 
ECM similar to native ligaments/tendons [13]. Resident 
tendon and ligament fibroblasts are the logical candidates 
for their regeneration. However, accessing them is dif-
ficult due to their intrasynovial location and exhibited a 
limited quantity and modest proliferative potential, which 
have restricted their usage. With the advancement of stem 
cell technology, pluripotent and multipotent stem cells for 
ligament/tendon tissue engineering have been more and 
more used [7] and include embryonic stem cells (ESCs), 
induced pluripotent stem cells (iPSC), bone marrow mes-
enchymal stem cells (BMSCs) and adipose-tissue-derived 
mesenchymal stem cells (AMSCs) [9].
The scaffold acts as a temporary engineered replace-
ment of the native ECM with similar mechanical and 
functional characteristics [14, 15] and will gradually 
degrade, being slowly resorbed by the surrounding tissue, 
and replaced while a new natural tissue is resynthesized 
[3, 7, 12, 16].
The scaffold should mimic the properties of the native 
tissue, not only in terms of mechanical function [17], but 
also proper topography, geometry and porosity to recre-
ate the native microenvironment and aid the cell adhesion, 
growth [14] and differentiation of the populating cells [17].
By labelling cells with quantum dots (QDs), it is possi-
ble to analyze variations in terms of number of cell popu-
lations adherent on different topographical regions, by 
counting cells labeled with QDs of the respective color. 
These QDs are readily incorporated by most cells’ lines 
and, at moderate concentrations and incubation times, 
do not cause acute cytotoxicity [18]. Besides, it has been 
found that the interaction between these nanoparticles 
and mesenchymal stem cells (MSCs) may influence their 
self-renewal, function and differentiation. Graphene-QDs, 
within a nontoxic concentration, promoted an osteogenic 
differentiation of MSCs, with gene activation and protein 
expression. Moreover, Graphene-QDs also promoted adi-
pogenic differentiation of MSCs, which confirms that the 
pluripotency ability of MSCs was preserved [19].
Pore interconnectivity throughout an implant favors 
the distribution of nutrients, cell migration, metabolic 
waste removal and the tissue ingrowth, enhancing its 
regenerative properties [6, 20]. The long-term clini-
cal success of scaffold also requires biocompatibility [6, 
14] which is the ability of a material to perform with an 
appropriate host response in a desired application. It is 
not only dependent on the material characteristics but 
also on the situation in which the material is used and 
the toxicity of the degradation products [21, 22]. To 
improve biocompatibility and biofunctionality, extracel-
lular matrix proteins and growth factors such as insulin 
like growth factor I (IGF-I), transforming growth factor-β 
(TGF-β) or basic fibroblast growth factor (bFGF) [7] have 
been incorporated into scaffolds to promote ligament/
tendon regeneration [23].
Regarding the regulatory aspects of these TE scaffolds, 
they are generally under the category of medical devices. 
Medical devices are products or equipment generally 
intended for medical use. In European Union (EU), they 
are strictly regulated by both national competent author-
ities and by the European Medicines Agency (EMA). The 
adopted regulation in EU for such devices is Regulation 
(EU) 2017/745 on Medical Devices. In USA, the extensive 
regulatory requirements are defined by FDA. Moreover, 
when TE scaffolds are combined with cells, the classifi-
cation of their category is not straightforward, depending 
on the cell type, and varying with the Regulatory Agency, 
e.g. FDA and EMA have distinct regulatory aspects. 
Also, their approval would be more complex: in fact, an 
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acellular scaffold should face less regulatory scrutiny than 
approaches utilizing allogeneic or xenogeneic cells, iPSC, 
ESCs, or even significant ex vivo manipulation of autolo-
gous cells. The introduction of cells as a component in 
TE introduces attendant risks associated with possible 
immunogenicity, teratoma formation, cell culture adap-
tation/morphogenesis, or contamination which must be 
addressed to assure safety. In summary, the regulation 
of TE products is time-consuming, with an average time 
from pre-clinical/clinical studies to the market of about 
15 years, and extremely high cost. There are already sev-
eral papers/book chapters in the literature just devoted to 
the clinical translation of TE constructs and the associ-
ated regulatory aspects [24].
Despite the variety of TE solutions and biodegradable 
polymers proposed for ligament/tendon TE, they haven’t 
yet reached the clinic or even pre-clinics because they still 
exhibited problems related to the inadequacy of mechani-
cal properties, degradation rate and biological response that 
are necessary to overcome [1]. For instance, there appears 
to be no consensus in the literature as to the nature of the 
scaffold material that is most suitable for clinical trials. So, 
further research is required to optimize tissue engineered 
ligament/tendon scaffolds before clinical application.
Thus, the selection of biodegradable and biocompatible 
materials with adequate degradation rate, structural and 
mechanical properties that mimic the organization of 
the ligaments/tendons represents a critical feature in the 
development of a successful scaffold.
Biodegradable polymers for ligament/tendon 
tissue engineering
Biomaterials are natural or synthetic materials designed 
to interact with the biological systems, with an intended 
function in the body or to treat, augment or replace any 
tissue or organ [25, 26]. Successful scaffolds should be 
biocompatible and maintain the mechanical properties 
until it is replaced by native tissue, disintegrating into 
smaller fragments along the replacement process, being 
absorbed and excreted by the body [27]. Understand-
ing the scaffold’s materials degradation behavior is very 
important when designing a new scaffold since it may 
alter its physicochemical properties and hence, its func-
tionality or even its biological response [28]. Thus, the 
scaffolds’ biocompatibility is intimately related to the 
scaffolds’ composition, which should not cause any sig-
nificant systemic inflammation or local reaction [29], but 
also to its biodegradation, since the degradation products 
should be nontoxic and metabolized by the body [17, 
29]. Scaffold’s polymer degradation rate plays an impor-
tant role in the cellular vitality and growth and should 
be similar to the rate of new tissue formation, allowing 
the occupation of the scaffolds’ space by the new tissue 
formed [29].
When in contact with surrounding fluids, polymers 
degrade by chain scission yielding low molecular weight 
species, oligomers and monomers [30]. All biodegrad-
able polymers contain hydrolysable bonds making them 
prone to chemical degradation via hydrolysis or enzyme-
catalyzed hydrolysis [29, 31, 32]. Synthetic polymers, 
in contrast to natural polymers, are less susceptible to 
enzymatic hydrolysis, and so tend to degrade by simple 
hydrolysis [33]. As a consequence of the water soluble 
degradation products (chemical phenomena), erosion of 
the material can occur (physical phenomena) [29].
Several natural polymers such as collagen (Col), silk, 
chitosan (CHI), hyaluronic acid (HA) and synthetic bio-
degradable polymers such as polylactic acid (PLA), poly-
glycolic acid (PGA), poly(lactic-co-glycolic acid (PLGA), 
poly(ε-caprolactone) (PCL), as well as biodegradable 
based polymeric composites have been used to produce 
scaffolds for tendon and ligament TE [1, 3, 5, 14, 34], in 
the form of gels, membranes, or three dimensional (3D) 
fibrous scaffolds.
PLA, PGA and PLGA are considered biocompatible, 
causing just minimal or mild foreign body reaction, since 
their hydrolytic degradation products (lactic and glycolic 
acids) are normally present in the metabolic pathways of 
the human body [30]. However, their bulk degradation 
may occasionally lead to local inflammation due to accu-
mulation of acidic degradation products that cannot be 
easily disposed. PCL is also biocompatible and degrades 
at a much lower rate than PLA, PGA, and PLGA, mak-
ing it attractive for long-term scaffolds such as tendon/
ligament scaffolds [30]. For instance, ACL regeneration 
and subsequent functionality usually requires at least 
6  months [35]. For such applications materials with a 
slower degradation should be selected [33, 35].
The polymer degradation rate is strongly influenced 
by several parameters such as the morphology, molecu-
lar weight and its distribution, crystallinity degree, glass 
transition temperature and environmental conditions 
(medium, temperature, and pH) [36]. It can be controlled 
by varying composition, molecular weight, processing 
conditions or even blending with biodegradable poly-
mers with different characteristics [12, 33]. For example, 
several degradation profiles and mechanical properties 
are possible to obtain just by using different fibers, com-
posed of materials with different degradation rates, and 
varying their diameter or architecture [33].
Most degradation experiments are performed in  vitro 
by incubating the scaffold in phosphate buffered saline 
(PBS) at body temperature (37 °C). However, in vivo deg-
radation is significantly different and occurs faster than 
in  vitro degradation due to the tissue response. Once 
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implanted, the scaffold is identified as a foreign body cre-
ating an inflammatory response. This induces the migra-
tion of leucocytes and macrophages to the implant site, 
forming reactive products as hydrogen peroxide that 
oxidize the polymer. The degradation products will be 
removed from the implantation site by the lymphatic 
system and subsequently secreted from the body. The 
in  vivo mass loss can be also increased by mechanical 
stimulations and cellular activity. Besides, the size and 
the shape of the scaffold influence its degradation rate. 
Larger implants require longer degradation times [30].
Most of the research for tendon tissue regeneration 
proposes the use of Col alone or mixed with other mole-
cules, such as proteoglycans, to produce scaffolds in form 
of sponges, aligned extruded Col fibers or electrochem-
ically-aligned Col [37]. Regarding ligament regeneration 
and specifically tissue-engineered ACLs, Col and the 
L enantiomer of PLA, Poly (L-lactic) acid (PLLA), have 
been the most used materials to produce biodegradable 
scaffolds, although some of them do not achieve more 
than 20% of the ultimate tensile strength of native ACL 
[8]. PLLA has demonstrated reasonable properties in 
terms of material strength and resorption rate [38], as 
well as it does not cause a permanent foreign body reac-
tion [11].
All the referred biodegradable polymers can be eas-
ily processed into fibers and fibrous scaffolds. However, 
each of these polymers has exhibited some inadequacies 
for tendon/ligament applications, such as inadequate 
mechanical properties and degradation rate [30]. Also, 
despite the variety of approaches on ligament tissue-
engineering, only a few of them were tested in vivo, using 
dogs, rabbits, goats and sheep [8].
Natural polymers
Natural polymers such as Col, alginate (ALG), CHI, HA, 
silk, fibrin and cellulose are attractive materials for bio-
medical applications due to their biocompatibility and 
capacity to structurally mimic the native ECM [39]. 
These polymers are capable of hydrolytic or enzymatic 
degradation [12], since they have a similar composition 
to macromolecular substances which are recognized by 
the biological environment and metabolized [40]. For 
that reason, the common problems caused by synthetic 
polymers are frequently avoided, such as stimulation of 
chronic immunological reactions and toxicity, as well as 
lack of cell recognition [25]. Natural polymers contain 
functional groups that allow a chemical conjugation with 
other molecules, such as growth factors [12, 41]. This fea-
ture may be beneficial for their further application in ten-
don/ligament scaffolds, as described in Table 1.
In spite of various advantages, natural polymers typi-
cally have relatively poor mechanical properties [44] 
and present low processing ability when compared to 
the synthetic ones, which limit their application [17, 
25]. Besides, these polymers often suffer batch-to-batch 
variability in molecular weight and purity, which repre-
sent low reproducibility amongst different samples of the 
same material [12, 17].
Collagen
The most obvious and common choice for ligament and 
tendon TE is Col type I because of its prevalence in the 
native tissues [3, 45–48]. It forms the connective tissue 
on which the fibroblasts adhere and proliferate [1, 39]. 
For that reason, Col was the first natural scaffold’s mate-
rial to be used in ligament reconstruction [1]. Purified 
Col derived from animal tissue requires crosslinking to 
remove foreign antigen, avoid potential disease transmis-
sion, improve its mechanical strength and slow down its 
degradation rate [33]. However, even after physical or 
chemical crosslinking of Col, the collagenous scaffolds 
fail to reproduce the mechanical properties of native 
collagenous tissues, the support of mechanical load-
ing decreases over time [13, 14] and suffer relatively fast 
in vivo degradation [33].
Dunn et  al. [46] extruded Col fibers and crosslinked 
them to produce collagen fibrous scaffolds. Rabbit ACL 
Table 1 Natural biodegradable polymers commonly used in tendon/ligament regeneration
Natural biomaterial Advantages Disadvantages
Collagen Biocompatible; major component of ligaments [7]; reasonable mechanical 
properties [9]
Poor mechanical strength; [7] risk of immuno-
genicity; [27] fast degradation [42]
Silk Good mechanical properties; slow rate biodegradation [9]; loses its strength 
after 1 year, in vivo [33]
Limited cell adhesion [7]
Alginate Biocompatible ECM component; can be in sponge or hydrogel form [7]; 
proper substrate for fibroblasts growth and collagen type I production [9]
Lacks mechanical properties [7]
Hyaluronic acid Biocompatible; can be in sponge or hydrogel form [7] Natural form with very short degradation time [43]
Chitosan Biocompatible; can be in sponge or hydrogel form [7]; proper substrate for 
fibroblasts growth and Col type I production [9]
Lacks mechanical properties [7]
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and patellar tendon (PT) fibroblasts were seeded onto 
Col scaffolds and adherence and viability in  vitro was 
found in both cases [46]. Bellincampi et  al. [47] deter-
mined the in  vivo fate of autogenous ACL and skin 
fibroblasts-seeded onto collagenous scaffold as a func-
tion of fibroblast source, implantation site and time. The 
cultured cells were seeded onto Col fiber scaffolds and 
implanted in rabbits. The seeded skin and ACL fibro-
blasts survived for at least 4–6 weeks after implantation 
and the fibroblast type seemed to have no influence on 
the viability. However, they verified a complete resorp-
tion of the scaffolds after 6 weeks [47].
Concerns about the Col mechanical performance, 
immunogenicity and leaching of chemical crosslinking 
agents have led to explore alternative scaffold materials 
[7, 13], such as silk, polysaccharides or synthetic poly-
mers. Nevertheless, new crosslinking strategies as well 
as scaffolds with a braid-twist design [7] or even decel-
lularized ECM-derived Col scaffolds [14] are still being 
explored to achieve Col scaffolds with more favorable 
properties for ligament regeneration. Walters et  al. [48] 
have recently developed Col type I fiber-based scaffolds 
for ACL ligament with a braid-twist design and evalu-
ated the effect of crosslinking method and the addition 
of gelatin on the mechanical properties. Although the 
crosslinked scaffolds without gelatin exhibit lower ulti-
mate tensile strength (UTS) than native human ACL but 
with a similar Young’s Modulus, improvements are still 
desired [48]. According to Noyes and Grood [49], ACLs 
from younger human donors (16–26 years of age) exhib-
ited a UTS of 37.8 ± 9.3 MPa and a Young’s modulus of 
111 ± 26 MPa [48].
Silk
Like Col, silk has been effectively used in ligament regen-
eration approaches [2, 16, 50–56] being easily fabricated 
into gels, films and braided or knitted fibers [3].
Its main advantage is its remarkable tensile strength 
and toughness compared to most natural materials 
although being lower than native human ACL [1]. Silk 
fibers lose their tensile strength in 1  year and undergo 
complete proteolytic degradation within 2  years in  vivo 
[7]. This allows a gradual transfer of mechanical load 
from the scaffold to the neoligament [57].
In addition, silk biomaterials are biocompatible  in 
vitro  and  in vivo [58]. Silk scaffolds have supported 
attachment and proliferation of several primary cells and 
cell lines [58], such as human BMSCs and fibroblast [55] 
as well as synthesis of fibroblastic markers with the appli-
cation of mechanical stimulation [7, 16].
Recently, Teuschl et al. [53] reported the braiding of silk 
fibers into wire rope–like structures to produce scaffolds 
that were boiled in borate buffer to remove sericin. The 
resulting silk ACL grafts were seeded with autologous 
stem cells and were able to stimulate ACL regeneration 
under in vivo conditions, using mountain sheep models. 
The seeded scaffolds exhibited UTS and elasticity val-
ues comparable to native ovine ACL [53]. Several tex-
tile methods such as twisting or cabling have been used 
to design TE scaffolds—see Fig.  1 [52].  Similarly, Chen 
et al. [55] and Altman et al. [16] showed that silk fibroin, 
is nonantigenic, biocompatible, and allow the BMSCs 
attachment, proliferation and differentiation toward liga-
ment lineage Fig. 2. 
In their study, Chen et  al. [55] studied wire-rope silk 
matrices and silk films, modified with a short polypep-
tide. Modified silk matrices improved human BMSCs 
and ACL fibroblasts adhesion and showed higher cell 
density and Col production, over 14  days in culture 
when compared with the non -modified matrices [55]. 
Fig. 1 a and b Structure of a twisted or cable yarn. Fibers are 
combined to form bundles, bundles to form strands, and strands 
to form cords. Yarns were labeled: A(a) × B(b) × C(c), where A, B, C 
represent the number of fibers/bundles/strands in the final structure, 
respectively and a, b, c is the number of turns per inch on each of the 
hierarchical levels (Adapted from [52])
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The 6-cord silk wire-rope scaffold produced by Altman 
et al. [16] not only supported the aforementioned attach-
ment, expansion and differentiation of BMSCs but also 
presented slow degradability and mechanical properties 
similar to those of the native human ACL [16]. Fan et al. 
[50] prepared a scaffold by rolling a knitted microporous 
silk mesh around a braided silk cord. MSCs seeded on 
these scaffolds [50] proliferated and differentiated into 
fibroblast-like cells by expressing collagen I, collagen III 
and tenascin-C genes in mRNA level. MSCs seeded scaf-
folds were implanted in a pig to regenerate the ACL. A 
remarkable scaffold degradation was observed, but the 
maximum tensile load of regenerated ligament was be 
maintained after 24  weeks of implantation. The tensile 
loss caused by the degradation of scaffold was compen-
sated by the new tissue formed. MSCs showed robust 
proliferation and fibroblast differentiation, at 24  weeks 
postoperatively [50].
Liu et al. [56] proposed a combined scaffold that incor-
porates microporous silk sponges into a knitted silk 
scaffold for ACL tissue engineering. BMSCs and ACL 
fibroblasts were seeded onto the scaffolds and cultured 
in vitro for 2 weeks. To evaluate the in vivo survivability, 
BMSCs or ACL fibroblasts seeded on each silk scaffold 
and implanted in rabbits were examined at 4 weeks post 
implantation. BMSCs presented advantages over ACL 
fibroblasts, in terms of cell proliferation, glycosaminogly-
can excretion, gene and protein expression for ligament-
related ECM markers, and in vivo viability Fig. 3 [56].
Polysaccharides
HA fibers are another natural-origin alternative for 
ACL replacement [43, 59]. HA is an anionic poly-
saccharide naturally present in all soft tissues, being 
responsible for the maintenance of the normal extra-
cellular matrix structure [43]. It is not immunogenic 
[43], being the main component of glycosaminoglycans, 
known for stimulating various in vitro tissue regenera-
tive processes. The natural form of HA is in gel and has 
a very short degradation time. For that reason, some 
chemical modifications have been proposed to improve 
its processability and biodegradation [43]. The biologi-
cal effects of HA, such as the improvement of cellular 
adhesion and proliferation as well as anti-inflammatory 
character, could enhance ligament tissue regeneration 
[60]. For example, Cristino et al. [43] seeded MSCs into 
the HA-based prototype ligament scaffold, and verified 
that MSCs cells completely wrapped the scaffold fibers 
Fig. 2 Scanning electron microscopy (SEM) showing adherence, proliferation and cell sheet formation by human BMSCs on the silk cord matrix 
prior to seeding (a), time 0 following seeding (b), 1 day (c), and 14 days (d). Scale bars = 100 mm (Reprinted with permission from [16])
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and expressed CD44, a receptor important for scaffold 
interaction, and typical ligamentous markers, such as 
collagen type I, type III, fibronectin, laminin, and actin 
[43].
CHI is a cationic polysaccharide with excellent adhe-
sive properties and biocompatibility which has led to its 
application as a scaffold material in the field of muscu-
loskeletal tissue engineering [60]. Due to their opposite 
charges, HA and ALG are usually combined with CHI to 
form polyionic complexes effective for scaffolds and with 
excellent adhesive properties [60, 61].
Table  2 summarizes the main studies that have used 
natural biodegradable polymers for ligament/tendon 
tissue engineering and highlights the major outcomes 
for the proposed scaffolds in terms of mechanical and 
in vitro/in vivo properties.
Synthetic polymers
Owing to their availability, ease of processability and 
reproducibility, synthetic polymers have been widely 
used to produce tendon/ligament scaffolds [14, 17]. Con-
trasting to the natural ones, synthetic polymers present 
low immunogenicity potential and are more versatile, 
enabling tailoring and controlling the chemical and phys-
ical properties [2].
Polyesters such as PCL and PGA, PLLA, poly(L-
lactide-co-ε-caprolactone) (PLCL) and PLGA have been 
effectively used to produce mechanically strong and bio-
degradable scaffolds for tendon/ligament applications-
Table  3 [14, 35]. These polymers are well characterized 
and have been approved by the FDA for certain human 
uses [37]. However, one of the disadvantages of synthetic 
polymers is the lack of biological cues for promoting cell 
Fig. 3 Fluorescence images of implants with silk scaffolds-with BMSCs (a) and ACL fibroblasts (b) at 4 weeks post implantation. Scale 
bars = 100 mm (Reprinted with permission from [56])
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adhesion and proliferation, which has to be overcome by, 
for example, applying a specific coating [37].
Poly‑α‑hydroxyesters
PLGA is a linear aliphatic polyester that contains lactide 
and glycolide as its monomers [39]. It has been consid-
ered an attractive choice for ligament/tendon regenera-
tion mainly due to its design flexibility and complete 
in  vivo bioresorption [6, 14, 70–72]. Moffat et  al. [70] 
produced a PLGA nanofiber-based scaffold for rotator 
cuff tendon tissue engineering. The influence of design in 
the attachment, alignment and gene expression of human 
rotator cuff fibroblasts on aligned and unaligned PLGA 
nanofiber scaffolds was evaluated. Aligned nanofiber 
scaffolds presented significantly better mechanical prop-
erties than those of the unaligned. The tensile modulus 
of the unaligned and aligned scaffolds averaged 107 MPa 
and 341  MPa, respectively, with mean ultimate tensile 
strength ranging from 3.7 to 12.0 MPa. The human rota-
tor cuff fibroblasts exhibited a phenotypic morphology 
and attached preferentially along the nanofiber axis of the 
aligned scaffolds, whereas only random cell attachment 
was observed on the unaligned scaffold [70].
Cooper et al. [6] proposed 3D braided scaffolds based 
on PLGA fibers, using a 3D circular braiding system 
and a rectangular braiding system for comparison. The 




PLLA Slow degradation rate (10 months to 4 years) [33], better cell adhesion than PGA or 
PLGA. Easily manufactured [7]
Acidic degradation [7]
PCL Easily manufactured; FDA approved material [7]; (over 3 years in vivo) [67] Very slow degradation rate [7]
PGA Easily manufactured; FDA approved material [7] Rapid (6–12 months) [68] and acidic degrada-
tion [7]; lack of signaling molecules [61]
PLGA Half-life of 1.5 months [68]; Degradation rate can be tailored by changing the ratio of 
PLA:PGA. Easily manufactured [7]
Acidic degradation [7]
PLCL Properties can be tailored by changing the ratio of PLA:PCL. Good biocompatibility and 
mechanical properties; easily manufactured [69]
Excessively elastic for tendon regeneration [69]
Fig. 4 General configuration of ligament scaffold design for 3-D rectangular braid, with 3 regions: femoral tunnel attachment site, ligament region, 
and tibial tunnel attachment site (Reprinted with permission from [6])
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3D circular fibrous scaffold has the highest tensile loads 
of 907 ± 132  N, which was greater than the level for 
normal human physical activity. The stress–strain pro-
file was found to be similar to that of natural ligament 
tissue. The scaffold porosity (175–233  mm) was ade-
quate for tissue ingrowth. An example of the scaffold 
design for 3-D rectangular braid and the corresponding 
load–deformation curves of the 3-D rectangular braids 
is shown in Figs.  4 and 5, respectively. Primary rabbit 
ACL cells and BALB/C mouse fibroblasts adhered and 
spread on scaffolds. Both types of cells grew on the rec-
tangular braided scaffold but only the ACL cells grew 
on the 3-D circular braids [6].
Braided and knitted scaffolds often require a gel sys-
tem for cell seeding. In order to overcome this limita-
tion, Sahoo et al. [71] proposed a biodegradable scaffold 
produced by electrospinning PLGA nanofibers onto a 
knitted PLGA scaffold. BMSCs were seeded on these 
scaffolds and on knitted PLGA scaffolds by immobiliz-
ing in fibrin gel. BMSCs produced abundant ECM with 
a higher expression of collagen-I, decorin, and biglycan 
on the scaffold with nanofibers demonstrating their 
potential to differentiate into tendon/ligament tissue.
The biodegradation of PLGA occurs mainly via chem-
ical hydrolysis of the hydrolytically unstable ester bonds 
into lactic acid and glycolic acid, which are non-toxic 
and removed from the body by normal metabolic path-
ways [36]. However, its biodegradation occurs within 
weeks, which results in complete loss of mechanical 
strength and compromise the integrity of PLGA-based 
scaffolds throughout the ligament healing period that 
generally extends to months [14, 73]. For that reason, 
PLGA is usually combined with other polymers, such as 
PLA [35].
Regarding PLA, it is a linear aliphatic polyester, an 
homopolymer containing only lactide subunits as mon-
omer [39]. It has a slow degradation rate [33] being 
widely suggested for several tendon-ligament scaffolds 
[11, 74–77]. It undergoes hydrolytic scission into lactic 
acid and is eliminated from the body mainly through 
respiration by the lungs, as  CO2 [78]. This degradation 
occurs within a period between 10  months to 4  years 
depending on its molecular weight, crystallinity, shape 
and site of the implant [79].
Cooper et  al. [74] cultured, in vitro, different types of 
cells derived from the ACL, medial collateral ligament 
(MCL), Achilles tendon (AT), and PT of rabbits on 3D 
braided PLLA scaffolds. This study revealed that all the 
primary connective tissue fibroblasts expressed genes 
associated with ligament differentiation but only PT 
and AT cells had the greatest in  vitro proliferation on 
3D braided scaffolds-Fig.  6. The 3D braiding geometry 
affected the matrix production of ACL cells, favoring the 
production of a filamentous matrix [74]. Lu et al. [72] and 
Laurencin et  al. [11] reported an affinity of ACL fibro-
blasts to PLLA scaffolds. According to Cooper et al. [6] 
PLGA scaffolds produced by a circular braiding achieved 
higher tensile loads. For that reason, Lu et  al. [72] also 
developed 3D braided PLLA scaffolds in a circular sys-
tem. They verified that ACL fibroblasts conformed to the 
geometry of these PLLA scaffolds, being the cell attach-
ment and proliferation increased when the scaffolds were 
coated with fibronectin (Fn). Fn is an important protein 
which is upregulated during ligament healing [72].
Fig. 5 Load-deformation curve and photomicrograph of mechanical failure of the 4 × 12 PLGA 3-D rectangular braids at a strain rate of 2%/s 
(Reprinted with permission from [6])
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Concerning PCL, it is a hydrophobic polyester with 
semi-crystalline structure, containing caprolactone subu-
nits [39]. It exhibits favorable biocompatibility, adequate 
mechanical strength, high elasticity as well as long deg-
radation time which has prompted its application in tis-
sue engineering [80]. Comparing to PLLA, PCL presents 
a slower degradation rate. However, its hydrophobicity 
may results in poor cell attachment and proliferation [81]. 
For that reason, when aiming tendon/ligament regen-
eration, PCL and derivatives are usually combined with 
other polymers such as CHI [82, 83], or simply coated 
with Col [80, 84]. In a study, electrospun PCL fibers were 
implanted in a rodent model for wound healing, showing 
evidences that PCL is nonimmunogenic, being integrated 
into local tissue without adverse reactions [85].
In order to compare these three biomaterials, in addi-
tion to braided PLLA scaffolds, Lu et  al. [72] also pro-
duced braided scaffolds made of PGA and PLGA to 
evaluate the effect of fiber composition on the mechani-
cal properties and biodegradation. The scaffolds were 
coated with Fn before the culturing with primary rabbit 
ACL cells. Although PGA presented the highest tensile 
strength, the rapid degradation conducted to scaffold fail-
ure. Pre-coating the scaffold surfaces led to an increase in 
cell attachment efficiency and overall cell proliferation. 
Based on the overall cellular response, with highest rates 
of ACL fibroblast proliferation, and its superior mechani-
cal and in  vitro slow degradation properties, the PLLA 
braided scaffold coated with Fn was considered to be the 
most appropriate scaffold for ACL tissue engineering 
Fig. 7.
Wagner et  al. [86] produced 3D porous polycaprolac-
tone fumarate (PCLF) scaffolds to mimic the anterior 
cruciate ligament. Porous scaffold molds were designed 
using SolidWorks CAD software and 3D-printed. The 
scaffolds were produced by UV cross-linking of the PCLF 
solution and then seeded with human AMSCs in human 
platelet lysate. AMSCs proliferated, filling the pores and 
exhibited a collagen-rich extracellular matrix. At day 14, 
Fig. 6 The cellular proliferation after culturing for 3, 7, 14 and 21 days 
on 5 × 5 PLLA 3D square braided scaffolds. The temporal cell growth 
of the ligament cells was slower as compared to the tendon cells [74]
Fig. 7 ACL fibroblast on braided scaffolds after 14 days of culture. Cells grown on braided scaffolds pre-coated with Fn elaborates a great amount 
of matrix compared to PLGA or PLLA scaffolds without Fn. Degradation of the PGA scaffold after 2 weeks of culture resulted in extensive cell loss 
and matrix depletion (Reprinted with permission [72])
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the cells remained viable and continued to increase in 
number, completely covering the surface and channels of 
the PCLF scaffold.
Table  4 presents a summary of the main studies that 
have used synthetic biodegradable polymers for liga-
ment/tendon tissue engineering and the outcomes for the 
proposed scaffolds in terms of mechanical and in vitro/in 
vivo properties.
Materials for ligament/tendon scaffolds
The difficulty of satisfying all the ideal scaffold require-
ments by using a single class of materials is a recurrent 
problem [39]. Advanced composite biomaterials have 
been fabricated to synergistically combine the beneficial 
properties of the constituents [39] and thus, achieving 
scaffolds that mimic complex structures of tendon/liga-
ments [92] and exhibit improved biological, biophysical 
and mechanical properties [2, 7, 12].
In the last years, the use of nanofillers (length < 100 nm) 
for the production of polymer nanocomposites has 
received great attention in academic research and indus-
try. Even with low nanofiller content, nanocomposites 
exhibited unique properties compared to conventional 
composites [93, 94]. The significant higher surface-to-
volume ratio of nanoparticles and their extremely higher 
characteristic ratio increase ductility with no decrease 
of strength and scratching resistance [95]. Besides, with 
the incorporation of nanoparticles in the polymer matrix, 
new properties may arise, which would not be possible 
when using macrosized particles [93]. Several nanocom-
posites with biodegradable polymer matrices have been 
developed specifically for various biomedical purposes 
such as drug delivery, tissue engineering, wound dress-
ings, stem cell therapy and cancer therapy [94, 95]. The 
specific use of biodegradable polymer matrices for the 
production of the nanocomposites offers great advan-
tages and include the ability to tailor mechanical proper-
ties and degradation kinetics to suit various applications 
[96]. Other advantages of using biodegradable matrices in 
TE approaches are their potential to fully restore the ten-
don or ligament tissues, with a simple surgical technique 
and minimal patient morbidity and risk of infection or 
disease transmission as well as rapid return to preinjury 
functions, by using biodegradable biomaterials scaffolds 
[1, 2, 12, 97].
Composites, blends and hybrid materials based on natural 
polymers
Scaffolds have been produced using collagen and sericin-
extracted silk to improve scaffold properties for tendon/
ligament applications and then seeded with cells [1, 98–
102]. Chen et al. [54, 98] embedded MSCs derived from 
human embryonic stem cells within a knitted silk-Col 
sponge scaffold and achieved an enhancement of tendon 
tissue regeneration. They demonstrated through in  vivo 
tests that dynamic mechanical stimulation is beneficial 
to tissue-engineered tendons, not only in terms of his-
tology but also for the mechanical performance [98]. A 
similar silk-Col scaffold for MCL regeneration, seeded 
with MSCs had higher mechanical properties than a silk 
scaffold. The silk scaffold elicited a mild inflammatory 
reaction and degraded slowly after subcutaneous implan-
tation in a mouse model [54]. Similarly, Shen et al. [99], 
Zheng et al. [100], Ran et al. [101] and Bi et al. [102] used 
scaffolds produced with Col micro-sponges in a knitted 
silk sponge matrix and all of them revealed efficient for 
tendon/ligament regeneration.
Bi et al. [102] evaluated the biomechanical performance 
of these silk-Col scaffolds and compared their perfor-
mance with an autograft Fig. 8. Scaffolds were sterilized 
and implanted in vivo, in 20 rabbits, and autologous sem-
itendinosus tendons were used to recover the ACL in 
the autograft control group. At 4 and 16 weeks after sur-
gery, grafts were retrieved and analyzed. After 4  weeks 
of surgery, the failure load in the scaffold group was sig-
nificantly higher than that in the autograft group (auto-
graft, 17.33 ± 3.43 vs. scaffold, 25.63 ± 4.17  N; P < 0.05, 
n = 5). After 16  weeks, there was no significant differ-
ence in the failure load between the two groups (auto-
graft, 27.64 ± 5.56 vs. scaffold, 31.85 ± 4.74  N, P > 0.05, 
n = 5; Fig.  8a). Regarding the stiffness, at 4  weeks post-
operatively, there was no significant difference between 
the two groups (autograft, 3.72 ± 1.19 N/mm vs. scaffold, 
5.78 ± 2.04 N/mm; P > 0.05, n = 5). However, at week 16, 
the stiffness in scaffold group was significantly greater 
than that of the autograft group (autograft, 3.63 ± 1.01 N/
mm vs. scaffold, 7.09 ± 1.25  N/mm; P < 0.05, n = 5; 
Fig. 8b). Thus, the scaffold provided enough mechanical 
strength to resist the daily activities of the experimental 
rabbits [102].
ALG is an anionic polysaccharide. Its combination with 
CHI was reported by Majima et al. [61] and improves its 
biocompatibility and cell adhesive potential as well as 
decreases its degradation rate. This in  vitro study using 
rabbit patellar tendon fibroblasts showed that ALG-0.1% 
CHI polyionic complex fibers had significantly higher cell 
attachment compared to ALG-only and polyglactin con-
trols [61, 92].
In another study of Majima et al. [60], a biocompatible 
braided scaffold was produced from melt spun fibers of 
CHI and 0.1% HA. The scaffold presents adequate bio-
degradability and biocompatibility, with intense collagen 
type I production. The reduction in the strength of the 
composite fibers, due to water absorption, was measured 
after incubation for 0 h, 2 h, 14 days and 28 days in the 
standard culture medium. The tensile strength decreased 
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after 2 h of incubation and then remained constant until 
28  days Table  5. In  vivo animal experiments with fibro-
blasts of Achilles tendon of a rabbit seeded on the CHI—
0.1% HA hybrid-polymer fiber scaffold, showed that the 
mechanical properties of the scaffold had the possibility 
to stabilize the joint [60].
A natural composite scaffold that combines silk, Col 
and HA was produced by Seo et  al. [103] for ligament 
regeneration. In that study, a silk scaffold was knitted by 
hand and dry coated with collagen‐HA followed by freeze 
drying. The initial attachment and proliferation of human 
ACL cells on the composite silk scaffold was higher than 
the observed on the silk scaffold. The Col-HA substrate 
on the silk scaffold enhances new blood vessel and cell 
migration in vivo [103].
Composites, blends and hybrid materials based on natural 
and synthetic polymers
Natural materials have the advantage of being biocom-
patible, recognizable by cells, favoring the cell adhesion 
and proliferation. However, their quick degradability and 
low- mechanical properties may limit their application in 
tissue engineering, while synthetic polymers present low 
bioactivity and higher mechanical properties [37]. Thus, 
the combination both types of materials is expected to 
yield a synergetic effect between natural and synthetic 
polymers [37], and has been proposed as a good compro-
mise between biological and mechanical performance for 
tendon and ligament regeneration [83, 104].
A hybrid scaffold comprised of degummed knitted silk 
microfibers coated with bioactive bFGF-releasing elec-
trospun PLGA fibers was produced by Sahoo et al. [105] 
and its feasibility for use in ligament/tendon was evalu-
ated in vitro. Rabbit BMSCs grew on PLGA fibers and silk 
microfibers and exhibited good viability. The release of 
bFGF stimulated cell proliferation and the gene expres-
sion of ligament/tendon-specific ECM proteins increased 
the collagen production and hence, the mechanical prop-
erties of the scaffold [105].
Three types of electrospun scaffolds of PLCL and silk 
fibroin, random nanofibrous scaffold, aligned nanofi-
brous scaffold and aligned nanoyarns (NRS), were stud-
ied by Yang et  al. [106]. The Young’s modulus value of 
the NRS was lower than that of the aligned nanofibrous 
scaffold but was approximately two times higher than the 
one of the random nanofibrous scaffold. However, ran-
dom and aligned nanofibrous scaffolds presented limi-
tations in terms of cell infiltration due to the dense fiber 
packing. NRS configuration provided larger pores and 
enough space for cell infiltration which yielded improved 
cell proliferation for up to 28 days of culture as it can be 
observed in Fig.  9. NRS are used to achieve a balance 
between the porosity and mechanical properties of elec-
trospun scaffolds [106].
Col has been widely combined with various polymers, 
often as a coating to stimulate tendon/ligament regenera-
tion [80, 81, 92, 107]. Similarly to the previously reported 
work of Yang et  al. [106], Xu et  al. [107] studied three 
morphologies (random nanofiber, aligned nanofibers and 
aligned nanoyarn) of electrospun scaffolds composed 
Fig. 8 Statistical evaluation of differences in failure load (a) and stiffness (b) between the autograft group and scaffold group at 4 and 16 weeks 
postoperatively. *Significant difference between groups [102]
Table 5 Tensile strength of  CHI-0.1% HA fiber after  0  h, 
2  h, 14  days and  28  days in  the  standard medium 
(Dulbecco’s modified Eagle’s medium). Adapted from [60]
n = 45 in each sample (mean ± standard deviation)
Incubation time Tensile strength (MPa)
0 h 213.3 ± 10.0
2 h 60.0 ± 6.7
14 days 66.7 ± 6.8
28 days 65.1 ± 6.6
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by PLCL and in this case, collagen type I, for tendon tis-
sue engineering. Nanoyarn scaffolds displayed desirable 
properties for tendon tissue engineering. Besides, tendon 
cells exhibited enhanced proliferation and expression of 
tendon-ECM genes on the nanoyarn scaffold, compared 
to random and aligned nanofiber scaffold [107].
Leong et  al. [80] evaluated electrospun PCL grafts 
coated with Col, with and without the addition of bFGF 
and hFF, using an athymic rat model of ACL reconstruc-
tion. The histological and mechanical evaluation of PCL 
scaffolds demonstrated excellent healing and regenerative 
potential. After 16  weeks of implantation, Col + bFGF 
grafts presented the highest stiffness, achieving 58.8% of 
the stiffness and 40.7% of the peak load of healthy native 
ACL. The implantation of cells on the scaffolds does not 
appear to be beneficial for ligament regeneration while 
the implantation of bFGF had a beneficial effect on the 
graft cellularity and mechanical properties [80].
Similarly, Petrigliano et  al. [84] used bFGF to treat 
PCL scaffolds (pre-coated with Col). Scaffolds were then 
seeded with BMSCs. Scaffolds treated with the growth 
factor and subjected to mechanical stimulation demon-
strated cellular adherence and spreading at 21 days.
Electrospun bundles containing PLLA and collagen 
type I in different percentages, PLLA/Col-75/25 and 
PLLA/Col-50/50, were tested by Sensini et  al. [104] 
to evaluate its potential for human Achille tendon 
regeneration. Human tenocytes were cultured over 
the same time range on the bundles and cell morphol-
ogy was assessed. The mechanical properties (stiff-
ness and strength) achieved are comparable to those 
of natural tendon. The PLLA/Col-75/25 blend was 
the most promising blend, with a Young modulus of 
98.6 ± 12.4  MPa (as-spun), similar to that of native 
ligament and 205.1 ± 73.0  MPa, after 14  days in PBS. 
A good cell attachment and viability after 14  days of 
culture was observed. However, cells exhibited a bet-
ter adhesion on PLLA/Coll-50/50 bundles and a more 
elongated morphology in comparison to PLLA/Coll-
75/25 one [104].
A co-electrospun scaffold with 3 regions containing 
PCL-Col, a mixture of PLLA/Col and PCL/Col fibers and 
PLLA-Col was studied by Ladd et  al. [108] for tendon–
muscle junction tissue engineering. The scaffolds exhib-
ited a randomly oriented nanofiber architecture in every 
region. The PLLA side had smaller fiber sizes on aver-
age, while the PCL side had larger fibers, and the center 
region, was a mixture of PLLA/Col and PCL/Col fibers 
with a fiber size in between. The scaffold was cytocom-
patible and accommodated cell attachment and myotube 
formation. Figure 10 shows the mechanical properties of 
this scaffold [108].
Sahoo et al. [81] reported the use of coating over PLLA 
and PLGA scaffolds, with PCL, PLGA nanofibers or colla-
gen type I. They verified that collagen type I coating over 
both the PLGA or PLLA scaffolds offers a very favorable 
surface for MSCs attachment and proliferation. PLLA 
scaffolds exhibited reduced cell proliferation due to its 
hydrophobic character [81].
Fig. 9 Commercially available cell counting kit-8 (CCK-8) result 
of MSCs cultured on the random nanofibrous scaffolds, aligned 
nanofibrous and NRSs for up to 28 days. The data are expressed as the 
mean ± SD. The samples marked with (*) has a significant difference 
between the two groups (P < 0.05) (Reprinted with permission from 
[106])
Fig. 10 Average parameters obtained from tensile testing to failure of each region (n = 9) and the whole scaffold (n = 10). a Young’s modulus, b 
Ultimate tensile strength, c Strain at failure. +, #, @ indicate statistical significance with P < 0.05 (Reprinted with permission from [108])
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In order to study the ability to use nanomaterials to 
effectively reinforce collagen, Green et al. [109] produced 
gel-spun collagen type I and carbon nanofibers compos-
ite scaffolds, with 0.5% and 5% of filling load, for tendon 
tissue engineering. Fibers were subjected to fiber elonga-
tion and were crosslinked with glutaraldehyde. Wet-state 
tensile testing indicates that the structure and mechani-
cal behavior are comparable to the native materials.
Other natural polymers such as CHI, ALG and HA 
have been combined with synthetic polymers [82]. For 
instance, Leung et al. [82] investigated aligned CHI–PCL 
nanofibers with TGF-b3 growth factor for tendon regen-
eration and they concluded that it led to a rapid and effec-
tive BMSCs differentiation into tenogenic progenitors 
[82]. Domingues et al. [83] reported the use of cellulose 
nanocrystals as reinforcing agents in aligned electrospun 
scaffolds containing PCL and CHI. The nanocomposite 
fibrous scaffolds fulfill the mechanical requirements for 
tendon TE applications and the aligned morphology pro-
moted a remarkable uniaxial cell orientation and induced 
elongated cell morphology [83]. A PLCL (lactic acid/ε-
caprolactone proportion of 85/15) multilayered braided 
scaffold was produced by Liu et al. [69] A layer-by-layer 
coating was introduced by immersing the scaffolds into 
poly-l-lysine solution (polycation) and subsequently into 
HA solution (polyanion) to promote MSCs growth, dif-
ferentiation, and migration. The braided PLCL scaffold 
with one-layer of poly-l-lysine and HA modification 
shows biocompatibility and satisfying mechanical prop-
erties that may constitute a promising scaffold for liga-
ment tissue engineering [69].
Composites, blends and hybrid materials based on synthetic 
polymers
The combination of different synthetic polymers has also 
been a strategic design for achieving hybrid scaffolds for 
ligament/tendon regeneration. For instance, although 
PLGA exhibits good cell affinity, it also presents a rapid 
degradation which limits its application in tissue engi-
neering. For that reason, PLGA may be combined with 
another material with slower degradation rate, such as 
PLLA to ensure the scaffolds’ integrity and adequate 
mechanical properties for a longer time. A PLLA-PLGA 
knitted scaffold was studied for ligament tissue engineer-
ing by Ge et  al. [35]. To understand the degradability 
of the biomaterial, in  vitro degradation tests were per-
formed, by immersing the knitted scaffolds in cell-culture 
medium for 20  weeks. As can be seen in Fig.  11, there 
was obvious mass loss at initial 4 week. This is possibility 
attributed to relatively quick degradation of PLGA, which 
may be important to promote potential tissue in-growth, 
at the initial stage of implantation. Comparing to PLLA 
yarns, PLGA yarns degraded more quickly and were not 
visible at 8 weeks. PLLA yarns kept their integrity for at 
least 20 weeks [35]. They found that this scaffold can ful-
fill most of the requirements in terms of porosity, degra-
dation rate and mechanical properties [35]. When seeded 
onto these scaffolds, MSCs proliferated and increased the 
synthesis of collagen type I and type III [110].
Pinto et  al. [111] reported the production of nano-
composite thin films containing PLA/COOH func-
tionalized carbon nanotubes (CNT-COOH) and PLA/
graphene nanoplatelets (GNP). In vitro tests were per-
formed by seeding human dermal fibroblasts (HDF) 
onto PLA, PLA/GNP and PLA/CNT-COOH films 
and all formulations exhibited no cytotoxic responses 
and supported cell proliferation up to 3  days in cul-
ture. After 72  h of in  vitro culture, HDF exhibited 
higher proliferation on the nanocomposite materi-
als with PLA/CNT 0.3% and PLA/CNT 0.5%, when 
compared to PLA. Besides, increasing percentages of 
CNT-COOH within PLA matrix did not affect cultured 
fibroblasts Fig. 12. In vivo tests performed by subcuta-
neous implantation of nanocomposites in mice showed 
no severe inflammatory response, as observed 1 and 
2 weeks after implantation, which supports that the use 
of carbon-based nanofillers in PLA-based structures 
has potential for ACL reinforcement [111].
In a previous study Pinto et al. [112] reported that the 
carbon nanostructures improved the mechanical prop-
erties of the PLA composites, approaching the range of 
natural tendons and ligaments: tensile strength in the 
range of 5–100 MPa and Young’s modulus from 20 MPa 
to 1200  MPa [113]. The composite with 0.7 wt% CNT-
COOH presented enhanced tensile strength relative 
to PLA (from 59.90 ± 4.93  MPa to 72.22 ± 1.52  MPa), 
as well as elongation at break (from 1.86 ± 0.06% to 
2.25 ± 0.40%) [112]. Besides, the composites with 0.7 
wt% CNT-COOH and 2 wt% GNP showed a consider-
able increase (> 20%) in the Young’s modulus relative 
to PLA, from 3.99 ± 0.42 GPa to 4.86 ± 0.47 GPa and 
4.92 ± 0.15 GPa, for PLA-CNT-COOH and PLA-GNP, 
respectively. The composite scaffolds were cytocompat-
ible, supporting fibroblasts metabolic activity and prolif-
eration up to 72 h [112].
Fig. 11 Mass loss of knitted structure during 20 weeks [35]
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Liu et  al. [114] produced a 3D biodegradable PLA 
screw-like scaffold coated with hydroxyapatite for ACL 
regeneration. The scaffold presented adequate size poros-
ity and the pores were interconnected in regular patterns 
with orthogonal structure. MSCs were seeded on PLA 
scaffold, PLA-hydroxyapatite scaffold, and suspended in 
Pluronic F-127 hydrogel on PLA-hydroxyapatite scaffold. 
The last group showed the highest in vitro cell prolifera-
tion and osteogenesis. For the histological examination, 
PLA, PLA-hydroxyapatite, and PLA-hydroxyapatite 
loaded MSCs screw-like scaffolds were implanted into 
the femoral tunnel of rabbits. The histological results 
revealed that PLA-hydroxyapatite scaffolds with MSCs 
seeded presented increased new bone formation at 
the interface between the bone tunnel and graft after 
12  weeks. Hydroxyapatite surface modification not only 
enhanced new bone ingrowth but also the proliferation 
and migration of MSCs and osteoblasts with excellent 
vascularization [114].
Sahoo et al. [81] reported that coating PLLA or PLGA 
scaffolds with collagen type I also offers a very favorable 
surface for MSCs attachment and proliferation. How-
ever, they verified that compared to Col, a PCL coating 
on PLLA or PLGA scaffolds resulted in a reduced cell 
attachment and higher mechanical strength [81].
A composite tendon scaffold composed of an inner 
part of PGA unwoven fibers and an outer part of knitted 
PGA/PLA fibers, to provide mechanical strength, was 
produced by Deng et al. [115], Fig. 13.
AMSCs were seeded onto these scaffolds [115]. Cyto-
compatibility between cells and PGA fibers was found 
since short-term in  vitro culture enabled AMSCs pro-
liferation and the production of extracellular matrix on 
the PGA fibers. The scaffolds exhibited a tensile strength 
Fig. 12 Viability (a) and proliferation (b) of fibroblasts seeded in different composites after 24 and 72 h in culture. Results are normalized with 
respect to the values for cells cultured in PLA control (Reprinted with permission from [111])
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around 50 MPa [115]. The in vitro cultured scaffolds were 
then subjected to an in  vivo transplantation on rabbits. 
Cell-seeded scaffold was integrated within the native 
tissue and with the increase of implantation time, cells 
gradually form neo-tendon. The diameter of collagen 
fibrils significantly increased which is related to the role 
of seeded AMSCs in the formation of engineered ten-
don in vivo Fig. 14. After 45 weeks of implantation, there 
was no obvious remaining scaffold-base material and the 
formed tendon exhibited a cord-like shape with a smooth 
surface, comparable to the normal tendon [115].
A summary of the studies that have used composites, 
blends and hybrid materials based on natural or syn-
thetic polymers for tendon/ligament TE are presented in 
Tables 6 and 7, respectively. A review about composites, 
blends and hybrid materials based on the combination 
of natural and synthetic polymers for tendon/ligament 
TE is presented in Table 8. These tables include, for each 
combination of materials, the proposed scaffold and the 
reported mechanical and in vitro/in vivo properties.
Processing techniques of ligament/tendon 
scaffolds
The architecture of the scaffold is an important design 
concern since it can modulate the mechanical and bio-
logical response and hence, determine the long-term 
clinical success of the scaffold [33]. Literature has 
reported several methods to produce tendon/ligament 
scaffolds including gas foaming, phase separation, emul-
sion freeze-drying and porogen leaching [66]. However, 
their ability to precisely control the pore size and inter-
connectivity as well as scaffolds’ structure and mechani-
cal properties is often limited [116].
Since both tendons and ligaments are fibrous tis-
sues, the production of fiber-based scaffolds has been 
the preferred option for tendon/ligament TE and has 
proven to promote cellular proliferation and collagen-
ous matrix deposition [9, 33]. The main factor is the 
way that fibers are organized. Parallel align of fibers/
yarns is the simplest way to organize fibers [9] and has 
been widely reported for tendon TE approaches [8, 
14, 83, 106, 107]. These fibers are commonly achieved 
through electrospinning [83, 106, 107] or electrochemi-
cal alignment [62, 122]. Figure  15 illustrates scanning 
electron micrographs of (A) aligned and (B) random 
nanofiber scaffolds proposed by Domingues et  al. [83] 
for tendon regeneration. However, the lack of interac-
tion between the fibers usually restrict its application 
[8]. Attending to the complexity of the ligament/ten-
don, the most common approach adopted by research-
ers relies on complex structures produced by textile 
techniques [116], in which fibers are engineered into 
Fig. 13 Preparation of a composite tendon scaffold. The scaffold was composed of an inner part of PGA unwoven fibers (a) and an outer part of a 
net knitted with PGA/PLA fibers in a ratio of 4:2 (b). The outcome of assembled two parts (c) (Reprinted with permission from [115])
Fig. 14 Quantification of collagen fibril diameter of in vivo 
engineered tendons with native tendon as a control. Collagen fibril 
diameter of in vivo engineered tendons increased with time. There 
was significant difference between 12 and 21 weeks, between 21 and 
45 weeks and between 12 and 45 weeks of the AMSCs seeded group 
(*P < 0.001). There was significant difference between two groups at 
45 weeks post implantation (*P < 0.001). Exp experimental group, Ctrl 
control group, w week, NRAT normal rabbit tendon (Reprinted with 
permission from [115])
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braided, knitted, twisted or woven structures to obtain 
hierarchical scaffolds [8, 9, 14].
Electrospinning allows the production of long continu-
ous fibers with controlled diameter ranging from nanom-
eters to microns, mimicking the nanoscale structure of 
tendon and ligament ECM [9]. It allows the production 
of fibers from several natural and synthetic polymers 
including Col, CHI, HA, silk fibroin [9] or PCL [91], 
PLGA [71], PLA [90], as well as combinations of natural 
and synthetic fibers [80, 83]. However, the weak mechan-
ical properties of the electrospun scaffolds produced 
for tendon/ligament TE limit the successful translation 
to the clinic [34]. Additionally, electrospinning typi-
cally produces 2D fiber mats, limiting the production of 
3D hierarchical structures. For that reason, electrospun 
nanofibers have been twisted or rolled using standard 
textile techniques such as e.g. weaving or braiding, to 
produce 3D hierarchical structures with proper mechani-
cal properties [34]. Yarns made of aligned fibers can be 
formed by electrospinning and then intertwined to form 
braided [88]  or knitted scaffolds as can be observed in 
Fig. 16 [105].
Textile technologies allow the production of complex 
3D constructs from monofilaments and multifilament 
threads, for various TE applications, being extensively 
applied in tendon/ligament regeneration [116]. These 
scaffolds are produced by several textile methods such 
as braiding, twisting, wire-rope, weaving and knit-
ting [52] that enable tailoring the scaffolds’ architecture 
by controlling the fiber size/orientation, pore size and 
interconnectivity, surface topography, mechanical prop-
erties and the cellular distribution that scaffold provides 
[116].
Twisted scaffolds are formed with multilevel yarns that 
combine multiple ends at a single point and twisting the 
structure together [52]. Twisted structures ensure inter-
action between fibers, unlike parallel aligned fibers, and 
are morphologically closer to native ligament, as depicted 
in Fig. 17b [8].
Knitting allows the production of complex structures 
from a yarn that is interlaced in a previous loop to form 
interconnected loops. Knitted scaffolds present differ-
ent mechanical and physical properties depending on 
the type of stitches and the yarn material. While the 
production of knitted structures with adjustable prop-
erties in different directions is difficult, it is possible to 
produce 3D structures with precise microstructure con-
trol by combining knitting machines with computer-
aided design (CAD) systems [116]. Knitted scaffolds for 
tendon/ligament tissue engineering [9, 103, 110] have 
demonstrated good mechanical properties and adequate 
porosity for tissue ingrowth Fig. 17c [71].
Braiding technique comprises three or more yarns 
intertwined in overlapping patterns [116]. In general, 
braided scaffolds are dimensionally very stable, having 
good flexibility, high strength and fatigue resistance [8]. 
These enhanced mechanical properties promoted their 
extensive application in tendon and ligament scaffolds 
with biomimetic characteristics [116]. The morphol-
ogy of the braided scaffolds made of PLCL and modi-
fied PLCL developed by Liu et al. [69] are illustrated in 
Fig. 18a as well as the global structure of the multilayer 
braided scaffolds (B). The mechanical and biological 
properties of these scaffolds were reported above.
Braided structures present low porosity which restricts 
the tissue ingrowth [8], as compared to the highly porous 
knitted structures that favor tissue ingrowth and the dep-
osition of collagenous connective tissue, which is crucial 
for tendon/ligament reconstruction [8, 71]. The pore size 
of braided structures may be controlled by varying the 
Fig. 15 SEM images of random nanofiber meshes and aligned 
nanofiber bundles of (a, b) PCL/CHI and (c, d) PCL/CHI/ cellulose 
nanocrystals (3wt.%) with the respective 2D-fast Fourier transform 
frequency plots. Scale bar 1 μm (Reprinted with permission from [83])
Fig. 16 BMSCs-seeded (7 days of culture) scaffold produced by 
electrospinning bFGF-PLGA fibers onto the surfaces of knitted 
microfibrous silk scaffolds [105]
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yarn size and braiding angle, which may also develop ani-
sotropic mechanical properties with adjustable gradient 
along any desired direction [116]. Laurencin et  al. [11] 
proposed a braided scaffold for ACL regeneration that 
comprised three regions: femoral tunnel attachment site 
(bony attachment end), ligament region (intra-articular 
zone), and tibial tunnel attachment site (bony attach-
ment end) as illustrated in Fig. 17a. The attachment sites 
exhibit a high-angle fiber orientation and smaller pore 
size to improve the quality of anchorage in bone tun-
nels and provide resistance to wear within it. The intra-
articular zone (central region with larger pore size) has a 
lower-angle fiber orientation. A minimum pore diameter 
of 150 µm is suggested for bone and 200–250 µm for soft 
tissue ingrowth [11].
Researchers have reported the production of yarns 
made of twisted fibers combined by the braiding process 
[75] in order to withstand it, since the degree of twisting 
as well as the direction affect the yarn strength, abrasion 
resistance, and flexibility [33]. Table 9 presents the braid-
ing and twisting angles associated to each braided scaf-
fold, braided-twisted scaffold and twisted scaffold [75].
An optical microscopy of a braided-twisted scaf-
fold for ligament regeneration developed by Leroy et al. 
[123], made of PLA combined with Pluronic or Tetronic 
(poly(ethylene oxide–propylene oxide co polymers), is 
illustrated in Fig.  19. Both types of scaffolds presented 
stress at failure compatible with that of ACL. Besides, 
in  vitro tests with MSCs revealed cytocompatibility of 
both scaffolds, suggesting that the twisted-braided shape 
did not cause any significant loss of cell viability and 
enhanced cell proliferation [123].
Other common approaches for ligament/tendon 
regeneration combine fibrous or spongy scaffolds with 
gels of fibrin, Col or HA, for cell seeding, attempting to 
improve their biocompatibility, but these exhibited lack 
of mechanical properties and are unstable in a dynamic 
situation, such as in the knee joint [33, 71].
Coating of scaffolds with Col, HA or nanofibers, as well 
as the addition of growth factors, has been reported [80, 
81, 103] as favoring cell attachment and proliferation, 
and ECM deposition [33]. The architecture of the scaf-
fold can be modified in terms of pore diameter, porosity, 
surface area, by varying the fiber composition, diameter, 
braiding and twisting angles as well as yarn density [33].
Most of conventional methods used to produce 
TE scaffolds lack the ability to obtain highly repeat-
able designs with precise, well-defined micro- and 
Fig. 17 Scaffolds for ligament tissue engineering. a Braided scaffold with a fibrous intra-articular zone terminated at each end by a less porous 
bony attachment zones in a single braid; b twisted fibrous scaffold; c silk scaffold produced by rolling up the porous knitted silk mesh around a silk 
cord (Reprinted with permission from [34])
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nanoscale structures [124]. 3D-printing enables the 
production of scaffolds with patient-specific require-
ments [124] and it has recently been suggested for the 
production of screw-like scaffolds for tendon/ligament 
scaffolds [114, 125]. This kind of scaffold could fix the 
tendon/ligament graft, and provide adequate space 
for bone ingrowth around the graft [114]. 3D printing 
offers control over the architecture of the scaffold, such 
as porosity, thus controlling physical properties [126]. 
It follows a procedure based on the layer-by-layer dep-
osition of the material, from bottom to top, to build a 
3D product directly from a CAD model [127, 128]. 3D 
processes provide increased speed, customization and 
efficiency, not involving toxic solvents [127, 129, 130]. 
Figure 20 illustrates a 3D printed PLA screw-like scaf-
fold developed by Liu et al. [114] for ligament applica-
tions, whose mechanical and biological properties were 
reported above.
Advances in 3D printing have increased feasibility 
towards the synthesis of living tissues-bioprinting [131]. 
This technology is based on a precise deposition of bio-
materials, either encapsulating cells or loaded with cells 
later on, and growth factors, in micrometer scale to pro-
duce a bioidentical tissue [131, 132]. Several research 
groups have bioprinted materials and cells for musculo-
skeletal applications including bone, cartilage, muscle, 
Fig. 18 a Morphology of PLCL scaffold and PLCL scaffold modified with poly-l-lysine and HA by scanning electron microscopy (SB: scaffold 
blank; SP: PLCL-poly-l-lysine; S1L: PLCL-poly-l-lysine/HA-PLCL-poly-l-lysine). b Global structure of the multi-layer braided scaffold. The six different 
constitutive layers, made of 16 fibers/layer, are represented with different colors (Reprinted with permission from [69])
Table 9 The braiding and  twisting angles associated 
to  each braided scaffold, braided-twisted scaffold 
and twisted scaffold. Reprinted with permission from [75]
a The twisting angles are arranged into structures (fiber bundles, yarns and 
scaffolds)
Scaffold levels Twisting  anglesa (degrees)
Fiber twisted to form fiber bundles 78 ± 3.4 69 ± 4.0 60 ± 4.5
Fiber bundles twisted to form yarns 83 ± 2.1 72 ± 2.3 62 ± 4.5
Yarns twisted to form scaffolds 79 ± 1.4 68 ± 3.8 62 ± 4.5
Scaffold 2 braid 4 braid 6 braid
Braiding angle (degrees) 78 ± 1.8 69 ± 2.7 61 ± 3.4
Fig. 19 Optical microscopy picture of the ligament tissue 
engineering scaffold (Reprinted with permission from The Royal 
Society of Chemistry [123])
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tendon and ligament tissues. However, there are signifi-
cant challenges to be resolved in terms of technological 
progresses [133, 134].
Conclusions
Tissue engineering is a promising alternative approach 
to the current surgery procedures for tendon/ligament 
repair. Its goal is to provide a complete regeneration of 
the damaged tissue, recovering its native architecture and 
functionality. A wide variety of biodegradable polymers 
and composites has been proposed for that purpose. 
Col and PLLA are the most used materials to produce 
biodegradable scaffolds. Given the complex structure of 
native tissues, the production of fiber-based scaffolds has 
been the preferred option for tendon/ligament scaffolds. 
Despite the remarkable progress made in this field, the 
current TE approaches still present limitations in terms 
of mechanical properties, degradation rate and biological 
response that are necessary to overcome. In the future, 
new strategies such as 3D printing may provide a rapid 
and promising solution for the production of tendon/
ligament scaffolds.
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scaffold surface with well-defined orthogonal structure (Reprinted with permission from [114])
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